PDF(513 KB)
PDF(513 KB)
PDF(513 KB)
类鼻疽的研究进展及诊疗现状
Progress on research and treatment of melioidosis
类鼻症是一种热带人畜共患病,以黏膜接触、吸入、摄入类鼻瘟伯克霍尔德菌的方式感染,临床表现为多发性脓肿、难治性肺炎及致死性败血症,病死率在40% 左右。主要流行区域在澳大利亚北部、东南亚,北美等地区也有散发病例报道。该病临床表现多样,转归迥异。极易误诊,抗生素耐药严重,治疗周期迁延及复发率高都是类鼻瘟诊疗中的难题。随着疫区输入性病例的增加和全球化的趋势,类鼻症的防治形势将变得更加严峻。鉴于临床医师尤其是非疫区医务人员对类鼻瘟疾病还很陌生,医护人员对病原感染的防护不足,本文结合最新文献报道,将类鼻症的诊疗及预防作简要综述,旨在加强医护人员对类鼻瘟疾病的认识,做好类鼻症的诊疗和预防以及个人防护。
Melioidosis, caused by the inoculation, inhalation and ingestion of Burkholderia pseudomallei, is a classical tropical amphixenosis characterized by multi-abscess , tough pneumonia and fatal septicemia. The mortality rate of this disease is up to 40%. Its endemic regions are mainly among North Australia, Southeast Asia, with sporadic cases reported from North America and other areas. Melioidosis may have a wide range of clinical manifestations, varying from an acute fulminant septic illness to a chronic infection. High misdiagnosis rate, high resistance rate and long period of antibiotic therarapy combined with high relapse rate are the major barriers to treatment . With the globalization and increasing risk of imported cases, it is necessary to effectively prevent and cure melioidosis. The current research progress and clinical advice are summarized in this paper.
Melioidosis / Burkholderia pseudomallei / Diagnosis and therapy
/
| 〈 |
|
〉 |